Molecular structure of (S)-(+)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid Monomethyl Ester, CAS Number: 76093-34-0
(S)-(+)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid Monomethyl Ester (CAS 76093-34-0)
CAS Number:
76093-34-0
Molecular Weight:
332.31
Molecular Formula:
C16H16N2O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
A1,4-Dihydropyridine derivative used in the prevention and the therapy of atherosclerotic degradation of arterial walls.
(S)-(+)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid Monomethyl Ester (CAS 76093-34-0) References
- New 1,4-dihydropyridine derivatives combining calcium antagonism and alpha-adrenolytic properties. | Marciniak, G., et al. 1989. J Med Chem. 32: 1402-7. PMID: 2542561
- Antiatherogenic properties of calcium antagonists. State of the art. | Weinstein, DB. and Heider, JG. 1989. Am J Med. 86: 27-32. PMID: 2653028
- Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. | Tamazawa, K., et al. 1986. J Med Chem. 29: 2504-11. PMID: 3023614
- Anti-atherosclerotic effects of calcium antagonists: a brief review. | Henry, PD. 1987. Clin Invest Med. 10: 601-5. PMID: 3326699
- Recent developments in the use of calcium antagonists in myocardial protection. | Gaviraghi, G., et al. 1995. Pharmacol Res. 31: 251-4. PMID: 7630866
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
(S)-(+)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid Monomethyl Ester, 10 mg | sc-208341 | 10 mg | $330.00 |